Literature DB >> 7128687

A purinergic component in the anticonvulsant action of carbamazepine?

J H Skeritt, L P Davies, G A Johnston.   

Abstract

The tricyclic anticonvulsant carbamazepine inhibited the binding of [3H]phenylisopropyladenosine (PIA) to rat brain membranes with a K1 value of 44 microM, which is in the range of therapeutic levels of this drug in brain and serum. Other anticonvulsants and tricyclic antidepressants had little effect on PIA binding. Carbamazepine weakly inhibited adenosine uptake into rat brain slices at 400 microM. An effect on adenosine receptors may be an important component of the anticonvulsant action of carbamazepine.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7128687     DOI: 10.1016/0014-2999(82)90512-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  11 in total

1.  4-aminopyridine and barium chloride attenuate the anti-epileptic effect of carbamazepine in hippocampal slices.

Authors:  H Olpe; C N Kolb; A Hausdorf; H L Haas
Journal:  Experientia       Date:  1991-03-15

2.  Purines and the Anti-Epileptic Actions of Ketogenic Diets.

Authors:  Susan A Masino; Masahito Kawamura; David N Ruskin; Jeremy Gawryluk; Xuesong Chen; Jonathan D Geiger
Journal:  Open Neurosci J       Date:  2010-01-01

3.  Differential effects of agents enhancing purinergic transmission upon the antielectroshock efficacy of carbamazepine, diphenylhydantoin, diazepam, phenobarbital, and valproate in mice.

Authors:  S J Czuczwar; B Szczepanik; A Wamil; W Janusz; Z Kleinrok
Journal:  J Neural Transm Gen Sect       Date:  1990

4.  Mood stabilizer psychopharmacology.

Authors:  Todd D Gould; Guang Chen; Husseini K Manji
Journal:  Clin Neurosci Res       Date:  2002-11-14

5.  Inhibition of agonist-stimulated inositol lipid metabolism by the anticonvulsant carbamazepine in rat hippocampus.

Authors:  E E McDermott; S D Logan
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

6.  Influence of CGS 15943 A (a nonxanthine adenosine antagonist) on the protection offered by a variety of antiepileptic drugs against maximal electroshock-induced seizures in mice.

Authors:  S J Czuczwar; W Janusz; B Szczepanik; Z Kleinrok
Journal:  J Neural Transm Gen Sect       Date:  1991

7.  Effects of carbamazepine and baclofen on 4-aminopyridine-induced epileptic activity in rat hippocampal slices.

Authors:  A E Watts; J G Jefferys
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

Review 8.  The use of carbamazepine in the treatment of schizophrenic and schizoaffective psychoses: a review.

Authors:  C Simhandl; K Meszaros
Journal:  J Psychiatry Neurosci       Date:  1992-03       Impact factor: 6.186

9.  Effects of carbamazepine on noradrenergic mechanisms in affectively ill patients.

Authors:  R M Post; D R Rubinow; T W Uhde; J C Ballenger; C R Lake; M Linnoila; D C Jimerson; V Reus
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

10.  Non-xanthine heterocycles: activity as antagonists of A1- and A2-adenosine receptors.

Authors:  J W Daly; O Hong; W L Padgett; M T Shamim; K A Jacobson; D Ukena
Journal:  Biochem Pharmacol       Date:  1988-02-15       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.